Brought to you by 
Veniti closes financing of over $17mm in Series C equity and debt
10 Mar 2015
Executive Summary
Veniti Inc. (devices for venous diseases) raised over $17mm through the sale of Series C equity and debt. Returning shareholders Baird Capital and Tekla Capital Management led the Series C portion and were joined by company participants. The senior secured debt funding was provided by Life Sciences Alternative Funding. The financing will support further development and eventual commercialization of its Vici Venous Stent system.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Veniti closes financing of over $17mm in Series C equity and debt
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice